Monotherapy of Hypertension with Angiotensin-Converting Enzyme Inhibitors
- 1 October 1984
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (4) , 128-134
- https://doi.org/10.1016/s0002-9343(84)80048-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Renal response to angiotensin-converting enzyme inhibitionThe American Journal of Cardiology, 1982
- Development and design of specific inhibitors of angiotensin-converting enzymeThe American Journal of Cardiology, 1982
- Angiotensin Converting Enzyme (ACE) InhibitorsAnnual Review of Pharmacology and Toxicology, 1982
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.BMJ, 1981
- Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure ResponseClinical Science, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977